A retrospective analysis of periodontitis during bevacizumab treatment in metastatic colorectal cancer patients

By Ogawa Kohei   Ueno Takao   Kato Ken   Nishitani Hitoshi   Akiyoshi Kohei   Iwasa Satoru   Nakajima Takako   Hamaguchi Tetsuya   Yamada Yasuhide   Hosokawa Ayumu   Sugiyama Toshiro   Shimada Yasuhiro  

International Journal of Clinical Oncology, Vol. 18, Iss. 6, 2013-12 ,pp. : 1020-1024

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of Bevacizumab-based Preoperative Radiochemotherapy in Patients with Locally Advanced Rectal Cancer on Surgery-associated Spectrum of Complications

By Dellas Kathrin   Buller Johannes   Görtz Gregor   Richter Michael   Höhler Thomas   Arnold Dirk   Keck Tobias   Dunst Jürgen   Zühlke Helmut  

Annals of Surgical Oncology, Vol. 21, Iss. 4, 2014-04 ,pp. : 1352-1360

Springer Publishing Company

Access to resources Recommend Favorite

Bevacizumab: In the Treatment of Colorectal Cancer

By Croom Katherine F.   Foster Rachel H.  

American Journal of Cancer, Vol. 3, Iss. 3, 2004-01 ,pp. : 187-194

Adis International

Access to resources Recommend Favorite

Bevacizumab-induced nasal septal perforation: Incidence of symptomatic, confirmed event(s) in colorectal cancer patients

By Ramiscal Judi Anne B.   Jatoi Aminah  

Acta Oncologica, Vol. 50, Iss. 4, 2011-05 ,pp. : 578-581

Informa Healthcare

Access to resources Recommend Favorite

Quality of treatment in routine care in a population sample of rectal cancer patients

By Engel Jutta   Kerr Jacqueline   Eckel Renate   Günther Bernulf   Heiss Markus   Heitland Wolf   Jauch Karl-Walter   Siewert Jörg Rüdiger   Hölzel Dieter  

Acta Oncologica, Vol. 44, Iss. 1, 2005-02 ,pp. : 65-74

Informa Healthcare

Access to resources Recommend Favorite